Added to YB: 2025-12-05
Pitch date: 2025-10-08
NBY [bearish]
NovaBay Pharmaceuticals, Inc.
-135.29%
current return
Author Info
No bio for this author
Company Info
NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally.
Market Cap
$128.5M
Pitch Price
$1.19
Price Target
0.05 (-98%)
Dividend
N/A
EV/EBITDA
-27.80
P/E
-1.01
EV/Sales
12.77
Sector
Pharmaceuticals
Category
special_situation
NovaBay Pharmaceuticals, Inc. - $NBY (short)
NBY short: Failed pharma co trading $1.20 vs 5c/share net cash. Oct 16 shareholder vote will approve massively dilutive convert preferred (120M shares at 5c = 95% dilution) + $200M shelf filed Oct 3. Buyer David Lazar has destroyed value at other cos. Auto-conversion post-approval creates 125.8M shares outstanding vs current 5.8M.
Read full article (4 min)